Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea

Journal of Medical Virology

Volumn 49, Issue 1, 1996, Pages 55-60

  Lee, Dong Soon ^a   Sung, Young Chul ^b   Whang, You Sung ^c  

^a Korea Cancer Center Hospital   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Central Red Cross Blood Center   (South Korea)

Author keywords

Distribution; Genotype; HCV; Korea

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CHRONIC LIVER DISEASE; CONTROLLED STUDY; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HUMAN; KOREA; LIVER CELL CARCINOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PREVALENCE; STRAIN DIFFERENCE;

BASE SEQUENCE; BLOOD DONORS; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DNA, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; KOREA; LIVER CIRRHOSIS; MOLECULAR SEQUENCE DATA; RENAL DIALYSIS;

FLAVIVIRIDAE; HEPATITIS C VIRUS; RNA VIRUSES; UNCLASSIFIED ORGANISMS;

EID: 0029992222     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199605)49:1<55::AID-JMV9>3.0.CO;2-J     Document Type: Article

References (50)

1. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G (1989): Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine 321: 1494-1500.
2. Albert J, Abrahamsson B, Nagy K, Aurelius E, Gaines H, Nystrom G, Fenyo EM (1990): Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107-112.
3. Alonso C, Qu D, Lamelin JP, de-Sanjose S, Vitvitski L, Li J, Berby F, Lambert V, Cortey ML, Trepo C (1994): Serological response to different genotypes of hepatitis C virus in France. Journal of Clinical Microbiology 32:211-212.
4. Bukh J, Purcell RH, Miller RH (1992). Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proceedings of the National Academy of Sciences USA 89:4942-4946.
5. Bukh J, Purcell RH, Miller RH (1993): At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proceedings of the National Academy of Sciences USA 90:8234-8238.
6. Cha TL, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS (1992): At least five related, but distinct, hepatitis C viral genotypes exist. Proceedings of the National Academy of Sciences USA 89: 7144-7148.
7. Cha TA, Beall E, Irvine J, Kolberg J, Chien D, Kuo G, Urdea MS (1993): At least five related but distinct, hepatitis C viral genotypes exist. Proceedings of the National Academy of Sciences USA 89: 7144-7148.
8. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989): Isolation of a eDNA clone derived from a blood-borne non-A, non-B, viral hepatitis genome. Science 244:359-362.
9. Chou WH, Lin SF, Sheu SH, Lu CF, Lin SY, Wu JS (1993): Comparison of hepatitis C virus strains obtained from hemodialysis patients. Japanese Journal of Medical Science and Biology 46:191-202.
10. Dussol B, Berthezene P, Brunet P, Roubicek C, Berland Y (1995): Hepatitis C virus infection among chronic dialysis patients in the south of France: A collaborative study. American Journal of Kidney Diseases 25:399-404
11. Feriyo EM, Morfeldt-Manson L, Chiodi F, Lind B, von Alber J, Olausson E, Asjo B (1988): Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. Journal of Virology 62:4414-4419.
12. Gracia-Valdecasas J, Bernal C, Gracia F, Cerezo S, Umana Wo, von Albertini B, Kimmel PL (1994): Epidemiology of hepatitis C virus infection in patients with renal disease. Journal of the American Society of Nephrology 5:186-192.
13. Hadiwandowo S, Tsuda F, Okamoto H, Tokita H, Wang Y, Tanaka T, Miyakawa Y, Mayumi M (1994): Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease or in maintenance hemodialysis in Indonesia. Journal of Medical Virology 43:182-186.
14. Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM (1991): Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates. Proceedings of the National Academy of Sciences USA 88:10292-10296.
15. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Okoshi S, Sugimura T, Shimotohno K (1990): Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences USA 87: 9524-9528.
16. Kato N, Ootsuyama, Ohkoshi S, Nakazawa T, Mori S, Hijikata M, Shimotohno K (1991): Distribution of plural HCV types in Japan. Biochemical and Biophysical Research Communications 181: 279-285.
17. Martell M, Esteban JL, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992): Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. Journal of Virology 66: 3225-3229.
18. McOmish F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL, Follett EA, Simmonds P (1993): Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33:7-13.
19. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R (1994): Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. Journal of Clinical Microbiology 32: 884-892.
20. Mizokami M, Mizoguchi N, Shibata H, Shibata H (1994): Significance of serological genotyping of hepatitis C virus in Japanese patients with chronic liver disease due to hepatitis C1. Rinsho Byori 42: 1015-1020.
21. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T (1994): Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Digestive Diseases and Sciences 39:977-982.
22. Mondelli MU, Cerino A, Bono F, Cividini A Maccabruni A, Arico M, Malfitano A, Barbarini G, Piazza V, Minoli, Silini E (1994): Hepatitis C virus (HCV) core serotypes in chronic HCV infection. Journal of Clinical Microbiology 32:2523-2527.
23. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai P, Chiewslip P, Kurimura T, Shimotohno K (1992): A new type of hepatitis C virus in patients in Thailand. Biochemical and Biophysical Research Communications 183:334-342.
24. Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T, Miyakawa Y, Mayumi M (1993): Genotypes dependence of hepatitis C virus antibodies detectable by the First-generation enzyme-linked immunosorbent assay with C100-3 protein. Journal of Clinical Investigation 92:1529-1533.
25. Nakao T, Enomoto N, Takada N, Takada A, Date T (1991): Typing of hepatitis C virus genomes by restriction fragment length polymorphism. Journal of General Virology 72:2105-2112
26. Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliner J, Gallo RC, Fischinger PJ, Goudsmit J (1990): Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. Journal of Virology 64:3779-3791.
27. O'Brien WA, Koyanagi Y, Namazie A, Zhao JQ, Diagne A, Idler K, Aack JA, Chen ISY (1990): HIV-1 tropism for mononuclear phagocytes can be determined by regions outside the CD4-binding domain. Nature 348:69-73.
28. Okamoto H (1992): Typing of hepatitis C virus genomes and its clinical application. Clinical Research and Clinics 1:20-29.
29. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Yoshizawa H, Tsuda F, Miyakawa M (1990): 5′ terminal sequence of the hepatitis C virus genome. Japanese Journal of Experimental Medicine 60:167-77.
30. Okamoto H, Okada S, Sugiyama Y, Kurai K, Izuka H, Machida A, Miyakawa Y, Mayumi M (1991): Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates from conserved and divergent regions. Journal of General Virology 72:2697-2704.
31. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992a): Typing hepatitis C virus by polymerase chain reaction with types-specific primers: Application to clinical surveys and tracing infectious sources. Journal of General Virology 73:673-679.
32. Okamoto H, Kurai K, Okada SI, Yamamoto K, Lizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S (1992b): Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 188:331-341.
33. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S (1993): Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. Journal of General Virology 74:2385-2390.
34. Pozzato G, Kaneko S, Moretti M, Croce LS, Franzin F, Unoura M, Bereich L, Tiribelli C, Crovatto M, Santini G, Kobayashi K (1994): Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. Journal of Medical Virology 43:291-296.
35. Ravaggi A, Zonaro A, Marin MG, Puoti M, Albertini A, Cariani E (1994): Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay. Journal of Clinical Microbiology 32:2280-2284
36. Resnick RH, Koff R (1993): Hepatitis C-related hepatocellular carcinoma, Prevalence and significance. Archives of Internal Medicine 153:1672-1677.
37. Saito I, Miyamura I, Ohbayashi A, Harada H, Katayama I, Kikuchi S, Watanabe Y (1990): Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proceedings of the National Academy Sciences USA 87:6547-6549.
38. Sakai A, Yanagi M, Unoura M, Kobayashi K (1994): Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus. Nippon Rinsho 52:1759-1762.
39. Shioda T, Levv JA and Cheng-Mayer C (1991): Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-169.
40. Simmonds P, Zhang LQ, Watson HG, Rebus S, Ferguson ED, Balfe P, Leadbetter GH, Yap PL, Peutherer JF, Ludlam CA (1990): Hepatitis C quantitation and sequencing in blood products, haemophiliacs, and drug abusers. Lancet 336:1469-1472.
41. Simmonds PF, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap OL, Kolberg J, Urdea MS (1993a): Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. Journal of General Virology 74:2391-2399.
42. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC (1993b): Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. Journal of General Virology 74:661-668.
43. Takamizawa A, Mori C, Fuke S, Manabe S, Murakami J, Fujita E, Onishi E, Andoh T, Yoshida I, Okayama H (1991): Structure and organization of the hepatitis C virus genome isolated from human carriers. Journal of Virology 65:1105-1113.
44. Tersmette M, Gruters RA, de Wolf F, de Goede REY, Lange JMA, Schellekens PTA, Goudsmit J, Huisman HG, Mieoema F (1989): Evidence for a role of virulent human immunodediciency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndromes: Studies on sequen HIV isolates. Journal of Virology 63:2118-2125.
45. Ulrich PP, Romeo JM, Lane PK, Kelly I, Daniel LJ, Vyas GN (1990). Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors elevated alanine aminotransferase. Journal of Clinical Investigation 86: 1609-1614.
46. Vadon-Doorn LJ, Kleter B, Stuyver L, Maertens G, Brouwer H, Schalm S, Heijtink R, Quint W (1994): Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles. Journal of Hepatology 21:122-129.
47. Weiner AJ, Geysen AM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunette M, Barr PJ, Miyamura T, McHutchinson, Houghton M (1992): Evidence for Immune Selection of Hepatitis C Virus (HCV) Putative Envelop Glycoprotein Variants: Potential Role in Chronic HCV Infections. Proceedings of the National Academy of Sciences USA 89:3468-3472.
48. Westervelt P, Gendelman HE, Ratner L (1991): Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proceedings of the National Academy of Sciences USA 88:3097-3101.
49. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M (1994): Hepatitis C virus genotypes are not responsible for development of serious liver disease. Digestive Diseases and Sciences 39:234-239.
50. Young KKY, Archer JJ, Yokosuka O, Omata M, Resnick RM (1995): Detection of hepatitis C virus RNA by a combined Reverse Transcription PCR assay: Comparison with nested amplification and antibody testing. Journal of Clinical Microbiology 33:654-657.